Onco-D-clare is a cancer screening test based on the interaction of molecular biology with machine learning algorithms. This screening test can help detect cancer before symptoms appear.

Peripheral blood mononuclear cells are isolated from blood samples, and gene expression analysis is performed in more than 90 genes. Their expression profile is then used for the classification of the sample as cancerous or healthy.

The Onco-D-clare test provides individuals with essential information to help them make better-informed decisions about future health and well-being.

The test is clinically validated and highly accurate (≈93%).